Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EXOSC9 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | DAB2 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-08 |
mRNA | BEND3 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
mRNA | LMNB1 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | FAM117B | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | CD151 | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-08 |
mRNA | RP11-426L16.10 | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-08 |
mRNA | CBX2 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | EWSR1 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | HMGB1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |